Planned sale of 7,663 shares under Rule 144

A holder of Common Stock in the issuer of symbol FLS has filed a notice under Rule 144 to sell up to 7,663 shares through J.P.

Accepted by SEC EDGAR 02/17/2026 - 04:13 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of Common Stock in the issuer of symbol FLS has filed a notice under Rule 144 to sell up to 7,663 shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of 686,528. The issuer had 127,115,509 shares outstanding. These shares were originally acquired as compensation in two grants on 05/25/2024 and 05/16/2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for FLS indicate?

The Form 144 indicates a shareholder plans to sell up to 7,663 common shares of the FLS issuer under Rule 144. It is a notice of proposed sale, not a guarantee that all shares will actually be sold.

How many FLS issuer shares are covered and what is their market value?

The filing covers up to 7,663 common shares with an aggregate market value of 686,528. This value is based on the market price used in the notice and helps show the approximate transaction size for this planned Rule 144 sale.

How many shares of the FLS issuer are outstanding in this filing?

The issuer has 127,115,509 common shares outstanding, according to the notice. This figure provides context for the planned sale of 7,663 shares, showing that the proposed transaction is small relative to the total share count.

When were the FLS shares being sold originally acquired?

The shares were acquired as compensation from the issuer on 05/25/2024 and 05/16/2025, in amounts of 4,453 and 3,210 shares. These compensation grants form the total of 7,663 shares now planned for sale.

Which broker and exchange are involved in the FLS Form 144 sale?

The planned sale is through J.P. Morgan Securities LLC, located at 270 Park Avenue in New York, and is designated for trading on the NYSE. This specifies the intermediary and marketplace for the proposed Rule 144 transaction.

What is the approximate planned sale date in the FLS Form 144?

The notice lists an approximate sale date of 02/17/2026. This date reflects when the shareholder expects to begin selling the 7,663 common shares on the NYSE through J.P. Morgan Securities LLC, subject to market conditions and Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001556386
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FLOWSERVE CORP
SEC File Number	001-13179
Address of Issuer	5215 N. O'CONNOR BLVD. Suite700 Irving TEXAS 75039
Phone	972-443-6500
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL C MCMURRAY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	7663	686528	127115509	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/16/2025	Compensation	Issuer			3210	05/16/2025	Compensation
Common Stock	05/25/2024	Compensation	Issuer			4453	05/25/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for MICHAEL C MCMURRAY.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)